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Abstract
Background: Metabolic control and dietary management of patients with phenylketonuria (PKU) are based on
single blood samples obtained at variable intervals. Sampling conditions are often not well-specified and
intermittent variation of phenylalanine concentrations between two measurements remains unknown. We
determined phenylalanine and tyrosine concentrations in blood over 24 hours. Additionally, the impact of food
intake and physical exercise on phenylalanine and tyrosine concentrations was examined. Subcutaneous
microdialysis was evaluated as a tool for monitoring phenylalanine and tyrosine concentrations in PKU patients.
Methods: Phenylalanine and tyrosine concentrations of eight adult patients with PKU were determined at 60
minute intervals in serum, dried blood and subcutaneous microdialysate and additionally every 30 minutes
postprandially in subcutaneous microdialysate. During the study period of 24 hours individually tailored meals
with defined phenylalanine and tyrosine contents were served at fixed times and 20 min bicycle-ergometry
was performed.
Results: Serum phenylalanine concentrations showed only minor variations while tyrosine concentrations varied
significantly more over the 24-hour period. Food intake within the patients’ individual diet had no consistent effect
on the mean phenylalanine concentration but the tyrosine concentration increased up to 300% individually. Mean
phenylalanine concentration remained stable after short-term bicycle-exercise whereas mean tyrosine concentration
declined significantly. Phenylalanine and tyrosine concentrations in dried blood were significantly lower than serum
concentrations. No close correlation has been found between serum and microdialysis fluid for phenylalanine and
tyrosine concentrations.
Conclusions: Slight diurnal variation of phenylalanine concentrations in serum implicates that a single blood
sample does reliably reflect the metabolic control in this group of adult patients. Phenylalanine concentrations
determined by subcutaneous microdialysis do not correlate with the patients’ phenylalanine concentrations in
serum/blood.
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Background
Phenylketonuria (PKU, OMIM 261600) is an autosomal
recessive disorder of phenylalanine (Phe) metabolism
caused by mutations in the PAH gene [1]. The enzyme
phenylalanine hydroxylase (PAH, EC 1.14.16.1), a cyto-
solic homotetramer, catalyzes the hydroxylation of Phe
to tyrosine (Tyr) using tetrahydrobiopterin (BH4) as a
cofactor [1]. PAH gene mutations may result in variable
degrees of enzyme deficiency [1]. In untreated PKU pa-
tients, the accumulation of Phe and a relative deficiency
in Tyr lead to neurological and cognitive impairment of
variable degree [1,2]. If initiated early, dietary treatment
by a Phe-restrictive and Tyr-supplemented diet can
prevent mental retardation and allows for normal intel-
lectual development [3], although several studies have
demonstrated subtle impairment of cognitive function in
affected patients [4]. Current guidelines recommend
regular monitoring of Phe levels by blood sampling at
age-adapted time intervals [3,5-7]. However, conditions
of blood sampling, such as the time of day, fasting or non-
fasting etc. are often not well-specified, and intermittent
variations of Phe levels between two measurements
remain unknown. Information on daytime variations of
Phe and Tyr concentrations and the influence of meals
and physical exercise are sparse. Several studies with small
groups of PKU patients – mainly children - have been
performed [8-13], yielding controversial results. Although
the long-term outcome of treated PKU patients over the
last decades suggests that diurnal variations of phenyl-
alanine and tyrosine concentrations are small in com-
parison with day to day variability and do not have a
major impact on the course of the disease, they are cer-
tainly of academic interest.
Subcutaneous microdialysis (MD) allows continuous
collection of samples from the interstitial space fluid of
subcutaneous adipose tissue. An advantage of this tech-
nique is the possibility of acquiring a series of diagnostic
samples without single blood drawings [14]. Although
the method has proved useful to determine in vivo tissue
concentrations of amino acids in healthy individuals
[15,16], it has not been studied in patients with PKU yet.
In MD a small semipermeable hollow fiber dialysis cath-
eter is inserted into the tissue [17]. A pump continuously
perfuses this catheter with a solution (perfusate) at very
slow rates (microlitres per min). Within the MD catheter,
the equilibrium with the environment (extracellular space
of the tissue) is achieved by means of diffusion of analytes
from the interstitial fluid into the perfusate through the
semipermeable membrane [18]. Diffusion through the
membrane is limited to soluble substances of low molecu-
lar weight [19].
This study addresses the question whether subcutaneous
MD may be helpful in the assessment of Phe and Tyr serum
concentrations. Therefore, amino acid concentrations in MD
fluid were compared to the concentrations in serum and
dried blood of adult PKU patients. Another aim of this
study was to elucidate if in adult PKU patients a single
blood sample can reliably reflect the overall metabolic
control and to examine to what extent the oral Phe intake
(within the patients’ individual dietary limits) and physical
exercise influence Phe and Tyr concentrations.
Methods
Patients
Eight adults with PKU (Phe concentrations in serum >
600 μmol/l, if untreated) were included in this study.
Age ranged between 20 and 44 years (median 31 years).
Details on age, sex, PAH mutations, daily Phe and Tyr
intake and daily amino acid supplements are displayed
in Table 1. All but one patient followed a Phe-restricted
diet. Patients with acute or chronic diseases other than
PKU, neuropsychiatric diseases, pregnant patients and
patients on regular medication other than oral contra-
ceptives or amino acid supplements were excluded from
this study.
Before inclusion in the study physical examination was
performed. Patients were examined during a 26-hour study
visit at the University Hospital in Freiburg, Germany. In-
formed written consent was obtained from all study parti-
cipants. Our study was approved by the Ethics Committee
of the University of Freiburg, Germany (149/10).
Schedule of the study visit
The schedule of the study visits is displayed in Figure 1.
Each study visit started at 9 am. Within the first two
hours a peripheral venous catheter was inserted and a
MD catheter was introduced into the periumbilical sub-
cutaneous adipose tissue. From 11 am on, serum and
dried blood samples were collected hourly. MD fluid
samples were also collected every hour and additionally
every 30 minutes between 2 and 12 pm and 8 and 10 am
to capture possible postprandial changes in amino acid
concentrations. During the study all patients continued
their regular individual diet including amino acid supple-
ments (Table 1). A diet protocol was written before the
study visit and the meals were prepared according to this
protocol during the study visit. Three meals with defined
Phe and Tyr contents were served at fixed times (Figure 1).
In addition, two snacks with a maximum Phe content of
190 mg were offered. Any remaining food was reweighed
and deducted from the total start weight. The exact pheny-
lalanine and tyrosine contents of all meals were calculated
by a dietician.
20 minutes of physical exercise by cycle ergometry was
perfomed between 9 and 11 pm. Ergometry was initiated
with 50 W and successively adapted (50 W increase
every two minutes) to patients’ heart rate to yield similar
physical exertion in all patients.
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Table 1 Study population of 8 PKU patients
Patient Age
(years)
Sex PAH gene
mutations
nucleotide
change
(Amino acid
change)
Phe intake
(mg/24 h)*
Phe intake
(mg/kg/24 h)*
Tyr intake (mg/24 h)# Tyr intake
(mg/kg/24 h)#
Amino acid supplements
(g protein/24 h)** (SD)##
Amino acid supplements
(g protein/kg/24 h)**Total
from food
from amino acid supplements
1 42 m
c.842C>T
1071 14
9057
115 80 (3) 1,0
(p.P281L) 6080
c.842C>T
2977
(p.P281L)
2 20 f n.a. 1653 35
1144
24 0 (0) 0,00
1140
3 22 f
c.842C>T
1142 12
6191
66 61 (3) 0,6
(p.P281L) 3660
c.842C>T
2531
(p.P281L)
4 32 m
c.580_581delCT
1083 13
5316
63 51 (3) 0,6
(p.L194Efs*5) 3060
2256
c. 782G>A
(p.R261Q)
5 32 f
c.473G>A
1395 19
5045
69 45 (3) 0,6
(p.R158Q) 2700
c.473G>A
2345
(p.R158Q)
6 26 f
c.1222C>T
1149 18
1378
21 0 (0) 0,0(p.R408W) 0
c.1066-3C>T 1378
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Table 1 Study population of 8 PKU patients (Continued)
(p.?)
7 28 f
c.782G>A
1090 13
8329
97 71 (3) 0,8
(p.R261Q) 4757
c.1222C>T
3572
(p.R408W)
8 44 f
c.60+5G>T
1556 26
4084
69 31 (3) 0,5
(p.?) 1266
c.727C>T 2818
(p.R243*)
* Phenylalanine intake (mg) during study visit calculated on basis of dietary protocols.
# Tyrosine intake (mg) during study visit calculated on basis of dietary protocols specified as total intake, tyrosine intake from food and tyrosine intake from amino acid supplements.
** Intake of amino acid supplements (g protein) during study visit.
## Distribution of amino acids supplements during study visit in number of single doses (SD).
m = male; f = female.
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Microdialysis and sample collection
The concentration of a particular substance in the per-
fusate relative to its concentration in the surrounding
medium (interstitial fluid) is called “relative recovery“
[17]. MD studies to evaluate the determination of glu-
cose in subcutaneous adipose tissue indicated that slow
flow rates (0.3-0.5 μmol/min) in combination with large
MD probes (30 mm membrane) allow almost complete
recovery of low molecular mass substances [20,21]. We
used a CMA 63 microdialysis catheter (CMA/Microdial-
ysis, Solna, Sweden) with a membrane length of 30 mm
and a diameter of 0.6 mm. The molecular exclusion size
of the polyamide membrane was 20 kD. The catheter
was perfused by a CMA 107 microdialysis pump at a
perfusion rate of 0.5 μl/min with Ringer solution, sam-
ples were taken hourly and postprandially half-hourly
(Figure 1). 7.1 μl microdialysate of every sample were
pipetted on special filter paper (Whatman [previously
Schleicher & Schuell] 903, obtained from GE Healthcare)
and dried at room temperature. Blood for amino acid
determination was collected in serum tubes (S-Monovette
9 ml, Sarstedt, Nümbrecht, Germany) and centrifuged
after coagulation (after 30 min). Serum samples were
stored in Eppendorf cups at −80°C until analysis. One drop
of freshly drawn whole blood was applied to filter paper
cards (see above) by the same person during all study visits
ensuring a comparable quality of dried blood samples.
Filter paper cards were dried at room temperature before
analysis.
Assessment of amino acid concentrations in serum, dried
blood spots and MD fluid
Phe and Tyr concentrations in dried blood spots and
dried microdialysate spots on filter paper were analysed
using tandemmass spectrometry (2795 Alliance HT
(HPLC), Quattro micro (tandem mass detector), Waters
GmbH, Eschborn, Germany). For internal quality control
reference filterspots with defined amino acid concentra-
tions (ClinChek® Whole Blood Control (filterspot) for
Acylcarnitines and Amino Acids, Level I and Level II, Lot.
105, Recipe Chemicals + Instruments GmbH, Munich,
Germany) were used and measured together with the pa-
tients’ samples. Results were considered reliable only if
both controls yielded concentrations within the reference
range provided by the manufacturer. Quality of dried
blood spot amino acid analysis was also ensured by par-
ticipation in the Newborn Screening Quality Assurance
Program for laboratory testing, Center for Disease Control
and Prevention, Atlanta, Georgia, USA and the Asso-
ciation of Public Health Laboratories, Washington, D.C.,
USA, and the Quality Assurance Program, LADR GmbH,
MVZ Dr. Kramer & Colleagues, Geesthacht, Germany.
Serum amino acids were determined after protein
precipitation with sulfosalicylic acid on a Biochrom B30
amino acid analyzer (Biochrom Ltd., Cambridge, England)
using ion-exchange chromatography followed by post-col-
umn derivatization with ninhydrin. External control was
performed using the corresponding INSTAND quality
control scheme (INSTAND e.V., WHO Collaborating
Centre for the Quality Assurance and Standardization in
Laboratory Medicine, Düsseldorf, Germany).
Statistical analysis
Statistical analysis was performed using IBM SPSS Statis-
tics 20. Before applying parametric tests, dependent vari-
ables were tested for deviations from normal distribution
by the Shapiro-Wilk test (p > .05 in 93% of the variables).
Wilcoxon signed-rank test was used to compare variation
coefficients of Phe and Tyr. To evaluate the short-term
effect of meals and exercise on Phe and Tyr concentra-
tions repeated-measures MANOVA were performed with
the within-subjects factor “time of measurement” (before
am am
Serum
Dried blood
MD fluid
11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10time 109
lunch dinner breakfastergometry
20 min
optional 
snack
optional 
snack
pm
Figure 1 Schedule of the study visit. Schedule of the study visit with meals and optional snacks at fixed times and bicycle ergometry at either
9.15 pm or 10.15 pm. The sequence of drawing blood samples (for serum and dried blood specimens) and the sequence of sampling
microdialysis fluid (MD fluid) are displayed as coloured dots.
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the meal, 60 min after the meal, 120 min after the meal).
To assess the correlation of Phe and Tyr concentrations
between different kinds of samples (serum, dried blood
and microdialysate) Pearson’s correlation coefficients (r)
were calculated for each patient, then transformed to
Fisher-Z values (Fisher r-to-Z transformation) and aver-
aged. Resulting mean Fisher-Z values were retransformed
to r values (reversed Fisher transformation).
Results
Serum Phe and Tyr concentrations
Mean Phe concentration in serum ranged between 687
and 1573 μmol/l. Mean Tyr concentration was between
39 and 89 μmol/l. There was very small variation in Phe
concentrations over the time studied (Figure 2). The
variation coefficient for Phe was 3% ([95% CI: 2.5–4.8],
whereas Tyr concentrations showed significantly greater
variation (variation coefficient 28% [95% CI: 19.3–36.2];
z = −2.52, p = .01 (Wilcoxon signed-rank test). The
mean variation in Phe concentrations in serum was 132
μmol/l (45 to 212 μmol/l). The mean variation in Tyr
concentrations was 68 μmol/l (18 to 134 μmol/l). The
highest Phe concentration in most patients was mea-
sured between 8 and 12 am. Almost all patients had
their lowest Tyr concentration before noon.
Short-term effect of meals on Phe and Tyr concentrations
The Phe consumption during the meals ranged between
172 and 725 mg per meal according to the patients` in-
dividual diet. Seven patients consumed amino acid sup-
plements (daily intake between 7 and 80 g) (Table 1).
The statistical analysis of the short-term effect of meals
on mean Phe and Tyr concentrations and the Phe:Tyr
concentration ratio ([Phe]/[Tyr]) is displayed in Table 2.
Preceding dietary intake lead to a significant change
(initial rise at 60 min followed by a decline at 120 min)
of mean Phe concentration in serum after breakfast
(p = .038) and lunch (p = .023) while no significant effect
was observed after dinner. Mean Tyr concentration did
not show any significant change after dietary intake while
mean [Phe]/[Tyr] declined significantly after breakfast
(p = .044) and lunch (p = .020).
Short-term effect of exercise on Phe and Tyr
concentrations
The results of the statistical analysis of the short-term
effect of exercise on mean Phe and Tyr concentrations
and [Phe]/[Tyr] are displayed in Table 3. While we could
not find any significant effect of short-time exercise on
the bicycle ergometer on mean Phe concentration in
serum we detected significant effects on Tyr concentra-
tion (p = .006) and [Phe]/[Tyr] (p = .031). Mean Tyr
concentration showed a slight rise within one hour after
exercise followed by a decline during the following hour.
Mean [Phe]/[Tyr] remained stable within the first hour
but increased thereafter.
Comparison of Phe and Tyr concentrations in serum,
dried blood and MD fluid
Amino acid concentrations measured in serum were sig-
nificantly higher than those measured in dried blood
(p <.0001) and MD fluid (p <.0001). The mean Phe con-
centration in dried blood was 72% (SD 3%, range 68–76%)
of the corresponding Phe concentration in serum. The
mean Phe concentration analysed in MD fluid yielded
only 56% (SD 12%, range 40–75%) of the serum concen-
tration. Similarly, mean Tyr concentrations in dried blood
and MD fluid were also lower compared to Tyr concentra-
tion in serum (70%, SD 3%, range 65–75% and mean 57%,
SD 12%, range 43-76%, respectively). The mean [Phe]/
[Tyr] in dried blood and MD fluid did not differ much
from serum values (103%, SD 3%, range 99–106% and
97%, SD 4%, range 91–104%, respectively) (Figure 3).
There was no linear correlation between the Phe con-
centrations in MD fluid and the corresponding serum
concentrations (r = −.11, p = .64). Correlation analysis for
Tyr and [Phe]/[Tyr] resulted in higher r values (r = .54,
p = .007 and r = .76, p < .001, respectively). Assuming that
changes of amino acid concentrations in the subcutaneous
compartment may occur with a certain delay, calculations
of Pearson’s correlation coefficient conducted with a delay
of one and two hours in MD fluid were performed. How-
ever, r values turned out to be even lower when a possible
delay was taken into account (Table 4).
Phe concentrations in dried blood and serum showed
a moderate correlation (r = .50, p = .014) whereas again
higher correlation coefficients for Tyr (r = .96, p < .001)
and [Phe]/[Tyr] (r = .96, p < .001) indicated stronger
correlation for these parameters (Table 4).
Discussion
Serum Phe and Tyr concentrations
Our results indicate that Phe concentrations in adult
PKU patients are subject to only very slight diurnal fluc-
tuations implicating that a single blood sample may re-
liably reflect the Phe-control in this group of patients.
Variation seems to be small especially in relation to the
daily mean Phe concentration. Several studies to eva-
luate the variations of Phe concentrations in PKU
patients have been performed in the past. Studying a
population of nine PKU patients (age 1 to 20 years) van
Spronsen et al. also observed only small daily fluctua-
tions of Phe concentrations especially when related to
the daily mean Phe concentrations [13]. However, amino
acid measurements in this study were limited to the first
half of the day (8.30 am −1.30 pm).
In contrast, McDonald et al. studied plasma Phe con-
centrations in 16 children (1 to 18 years) with PKU over
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a time period of 24 hours [11]: The median difference
between highest and lowest concentrations observed
(155 μmol/l/day) did not differ much from the results
found in our study cohort (132 μmol/l/day). However,
as they studied mainly children under a more Phe-re-
stricted diet, fluctuation of the Phe concentrations in re-
lation to the patients’ daily mean values was much
higher compared to our data from adult patients.
Ferguson studied twelve young PKU patients (9 to 15
years) under different regimens of Phe intake and dis-
tribution of protein substitute and found marked differ-
ences of serum Phe profiles even within the same group
[9]. Both studies lead to the conclusion that single sam-
ples give an incomplete and non-representative indica-
tion of Phe-control in many children with PKU.
We could confirm earlier observations by van Spronsen
et al. that Tyr concentrations show larger diurnal varia-
tions than Phe concentrations [13]. The greater variability
could be explained by the high content of Tyr in the
amino acid supplements taken by the majority of patients
and the relatively small plasma pool, resulting in higher
proportional changes.
In accordance with earlier reports, we found maximum
Phe concentrations for most patients during the morning
Phenylalanine
time
11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10
P
he
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on
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nt
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n 
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m
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/l)
0
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1500
2000
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pm am
pm
Tyrosine
time 
11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10
T
yr
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n 
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m
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0
50
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150
200
lunch dinner breakfastergometry
ergometrylunch dinner breakfast
Figure 2 Variation of phenylalanine and tyrosine concentrations in serum over 24 hours. Profiles of phenylalanine (Phe) and tyrosine (Tyr)
concentrations in serum of all patients during the 24-hour study visit. Time of main meals and bicycle ergometry is displayed.
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hours (8 am - 12 am) [8,10-13]. An overnight rise in Phe
concentration is generally thought to be a result of protein
catabolism in the fasting state [22]. However, we did not
find a linear overnight rise in Phe concentrations in serum
as suspected by Farquhar et al. [8]. Nevertheless, as
highest Phe and lowest Tyr concentrations were found in
the morning, blood sampling for the monitoring of amino
acid concentrations in PKU patients should preferably be
done at this time of day.
Short-term effects of meals on Phe and Tyr
concentrations
In healthy individuals Phe and Tyr concentrations rise sig-
nificantly after meals [23]. Fingerhut et al. studied amino
acid concentrations in dried blood spots of 92 probands
(< 1 to 48 years) and found postprandial increases of Phe
and Tyr concentrations of 18% and 14%, respectively [23].
We did not observe a consistent effect of food intake on
mean Phe concentration in serum. While after breakfast
and lunch a significant rise in Phe levels was observed no
such effect became evident after dinner. Notably, in our
study setting the patients received their regular diet and
the effect of excessive Phe intake was not tested. It needs
to be taken into account that mean Phe levels in our pa-
tients were much higher than in healthy controls. There-
fore, even if the absolute postprandial increase of Phe
concentration was the same, the percental change was
much lower and thus yielded no statistical significance. In
contrast, Tyr concentration increased to more than 300%
in individual patients, especially after additional ingestion
of amino acid supplements rich in Tyr.
In a study with nine PKU patients van Spronsen et al.
also found Phe concentrations to remain rather stable
(postprandial increase to 116%) when compared to post-
prandial Tyr concentrations that were as high as 548%
in single patients [13].
In a different study by the same authors plasma Phe
responses to different distributions of the daily Phe allo-
wance over the day were tested in seven PKU patients
(1 to 20 years) [12]. Even after single meals containing
Table 2 Short-term effect of meals on mean phenylalanine and tyrosine concentrations and the phenylalanine:
tyrosine concentration ratio in serum
Before meal 60 min postprandial 120 min postprandial
Variable M SD M SD M SD F(2,6a) p
Phe
Breakfast 1053 278 1071 257 1040 262 6.74 .04
Lunch 1098 286 1109 288 1082 288 7.59 .02
Dinner 1091 282 1078 280 1059 288 2.60 .15
Tyr
Breakfast 46 6 70 35 84 42 2.54 .17
Lunch 50 14 74 45 69 31 1.89 .23
Dinner 72 20 82 28 84 25 1.59 .28
[Phe]/[Tyr]
Breakfast 23 5 18 8 15 7 6.19 .04
Lunch 24 10 19 10 19 10 8.01 .02
Dinner 16 5 15 5 14 6 1.36 .32
Phe = phenylalanine; Tyr = tyrosine; [Phe]/[Tyr] = phenylalanine: tyrosine concentration ratio.
aExcept for breakfast: n = 7 and therefore denominator df = 5.
To evaluate the short-term effect of meals on phenylalanine and tyrosine concentrations and the phenylalanine: tyrosine concentration ratio in serum repeated-
measures MANOVA were performed with the within-subjects factor “time of measurement” (before the meal, 60 min after the meal, 120 min after the meal).
Table 3 Short-term effect of exercise on mean phenylalanine and tyrosine concentrations and the phenylalanine:
tyrosine concentration ratio in serum
Before exercise 60 min after exercise 120 min after exercise
Variable M SD M SD M SD F(2,6) p
Phe 1057 287 1058 291 1050 286 1.46 .30
Tyr 82 25 85 30 69 25 13.31 .01
[Phe]/[Tyr] 14 7 14 7 17 9 6.50 .03
Phe = phenylalanine; Tyr = tyrosine; [Phe]/[Tyr] = phenylalanine: tyrosine concentration ratio.
To evaluate the short-term effect of exercise on phenylalanine and tyrosine concentrations and the phenylalanine:tyrosine concentration ratio in serum repeated-
measures MANOVA were performed with the within-subjects factor “time of measurement” (before the exercise, 60 min after the exercise, 120 min after
the exercise).
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75% of the individual daily Phe allowance an increase of
mean plasma Phe concentration of only 13% was ob-
served. Extreme peak concentrations of Phe were not
detected and the rises were only transient with Phe levels
returning to baseline values within two to three hours.
Similarly, MacDonald et al. who monitored Phe concen-
trations in 16 PKU patients (1 to 18 years) over a 24-hour
period found no rise in Phe levels in response to Phe
consumption [11].
In a recent study, van Rijn et al. investigated the effect
of an additional Phe load on blood Phe concentrations
in six adult patients [24]. In this study population Phe
concentrations before the study were within the target
range of 120–600 μmol/l. Phe loads equivalent to 100%
and 200% of each patient’s individual daily Phe intake
were given once per week and Phe concentrations in
dried blood spots were measured in daily intervals.
Mean Phe concentration during the days before the Phe
load did not differ significantly from days after the load
suggesting that an extra, incidental intake of 100% - and
in some cases 200%- of the individual daily Phe intake is
tolerated by patients with well-controlled PKU.
Twenty- four- hour variability in blood Phe concentra-
tion could also be affected by the amount and distribution
of Phe-free amino acid supplement. MacDonald et al.
found strong negative correlation between the amount of
protein substitute taken by the time of the evening meal
and the change in plasma Phe concentrations during the
day. The more protein substitute was taken early in the
day, the greater was the fall in plasma Phe concentrations
during the course of that day [10]. In all of our study pa-
tients taking relevant amounts of amino acid supplements
the doses were distributed evenly throughout the day.
Therefore, we can draw no conclusions on the effects of
an uneven distribution on the variability in blood phenyl-
alanine concentrations.
Short-term effects of exercise on Phe and Tyr
concentrations
Our short-term endurance training (ergometry) showed
no significant effect on mean Phe concentration within
the two hours after the exercise. In contrast, the mean
Tyr concentration showed a slight, albeit significant in-
crease within one hour and a sharp decrease during the
following hour. To our knowledge, no data are available
with respect to the short-term effects of exercise on
amino acid concentrations in PKU patients so far. It has
been shown that in healthy individuals exercise may
have a profound acute effect on protein metabolism
[25]: Although protein is not normally an important en-
ergy source for exercising muscle, there is a significant
increase in the rate of amino acid catabolism during
exercise [26]. Furthermore, an increase of whole body
protein breakdown has been documented in several
studies [27-29]. In the post-exercise state, however,
whole body protein synthesis occurs [30], [25]. Phe and
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Figure 3 Phenylalanine and tyrosine concentrations as well as phenylalanine:tyrosine concentration ratio in dried blood spots and MD
fluid relative to serum values (100%). Mean and standard deviation of phenylalanine (Phe) and tyrosine (Tyr) concentrations and of the
phenylalanine:tyrosine concentration ratio ([Phe]/[Tyr]) in dried blood and microdialysis fluid (MD fluid) relative to the corresponding serum
values (100%).
Grünert et al. Nutrition Journal 2013, 12:60 Page 9 of 12
http://www.nutritionj.com/content/12/1/60
Tyr can neither be synthesized nor degraded by skeletal
muscle and thus provide a measure of the net rate of
protein degradation (i.e. the rate of protein degradation
minus the rate of protein synthesis) [26]. An increase in
plasma concentrations of both amino acids between 20–
90% during exercise has been reported in some studies
[31-33] while other authors found Phe and Tyr concen-
trations to remain stable [30].
As Phe released by protein breakdown cannot be meta-
bolized normally in patients with PKU, more pronounced
effects could be expected compared to healthy persons.
However, the fact that we have observed very stable Phe
concentrations during and after exercise implicates that
short-term sportive activity and the concomitant protein
breakdown do not put adult patients at risk for extreme
peak concentrations of Phe.
Comparison of amino acid concentrations in serum and
dried blood
Amino acid analysis in dried blood spots by tandem
mass spectrometry yielded lower concentrations (−28%)
compared to the corresponding serum levels. It was tried
to reduce common errors in the application of whole
blood on filter paper cards by the fact that all dried
blood samples were prepared by the same person. The
concentration difference between serum and dried blood
can be explained by the volume displacement effect [34]
in samples containing cellular matter. Deproteinization
and centrifugation of serum eliminates the volume frac-
tion of cellular components and distributes the remaining
soluble analytes in a smaller volume, thus resulting in a
higher concentration value [35]. Because amino acid
analysis in dried blood spots is commonly used in the
long-term monitoring and dietetic management of PKU
patients, it has to be noted that corresponding Phe con-
centrations in serum are significantly higher.
Notably, we found an unexpectedly poor correlation
between Phe concentrations in serum and dried blood
spots, whereas Tyr concentrations correlated to a higher
degree. As the same analytical methods and samples
were used for both amino acids, this lack of correlation
is probably not due to preanalytical or analytical diffe-
rences. We hypothesize that due to stability of Phe con-
centrations with fluctuations of only 3%, subtle changes
in Phe concentration may have been masked by ana-
lytical errors resulting in the poor correlation of the two
methods. More pronounced changes in blood Tyr con-
centration led to better statistical correlation.
Comparison of amino acid concentrations in serum and
MD fluid
In our patients the mean Phe concentration measured in
MD fluid reached only approximately 60% of the con-
centration measured in serum. Rolinski et al. studied the
determination of amino acid concentrations by subcuta-
neous MD in nine newborn infants [16]. In contrast to
our results, they found higher concentrations of Phe and
Tyr in MD fluid compared to plasma (108% and 127% of
the corresponding plasma concentration, respectively).
Thus, it was concluded that these amino acids are syn-
thesized and/ or released by the subcutaneous tissue
[16]. However, it has to be taken into account that tissue
composition and metabolic activity of the subcutis in
newborns may differ considerably from those in adults
[16]. Furthermore, Rolinski et al. studied newborns with
hypoglycemia. Since this may prompt proteolysis in
order to enable gluconeogenesis, it can be hypothesized
that protein catabolism may have contributed to higher
tissue amino acid concentrations in the newborns. Inde-
pendent of the patients’ age the position of the catheter
can have a major impact on the relative recovery because
vascularisation of the tissue influences the diffusion rate.
The position of the catheter in the deep adipose tissue
with low metabolic activity would therefore be associated
with lower amino acid concentrations in the MD fluid.
We found no significant correlation between Phe con-
centrations in MD fluid and serum. As already discussed
above, the low variability of Phe concentrations could be
a complicating factor impeding good correlation results.
On the other hand, Rolinski et al. have shown that
amino acid values in MD fluid only partly reflect plasma
values [16] and suspected a tissue specific amino acid
pattern in subcutaneous tissue. As we have only deter-
mined Phe and Tyr concentrations instead of a more
Table 4 Correlation of phenylalanine and tyrosine
concentrations and phenylalanine: tyrosine concentration
ratio between different types of samples
Real time Delay 1 h Delay 2 h
Variable r p r p r p
Correlation between serum and dried blood
Phe .50 .01
Tyr .96 < .001
[Phe]/[Tyr] .96 < .001
Correlation between serum and microdialysate
Phe -.11 .64 -.15 .48 -.24 .25
Tyr .54 .01 .23 .28 .04 .84
[Phe]/[Tyr] .76 < .001 .52 .01 .28 .18
Phe = phenylalanine; Tyr = tyrosine; [Phe]/[Tyr] = phenylalanine: tyrosine
concentration ratio.
The correlation analysis of phenylalanine and tyrosine concentrations and of
the phenylalanine: tyrosine concentration ratio ([Phe]/[Tyr]) between
microdialysis fluid and serum was performed with samples taken
simultaneously (“Real time”) and with microdialysate samples taken one hour
(“Delay 1 h”) and two hours (“Delay 2 h”) after blood sampling. To assess the
above-mentioned correlations Pearson’s correlation coefficients (r) were
calculated for each patient, then transformed to Fisher-Z values (Fisher r-to-Z
transformation) and averaged. Resulting mean Fisher-Z values were
retransformed to r values (reversed Fisher transformation).
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comprehensive amino acid pattern, we can neither con-
firm, nor disprove their hypothesis.
Assuming a possible delay in reaching an equilibrium
between amino acid concentrations in serum and adipose
tissue, we additionally performed correlation analysis with
a delay of one and two hours. Such a time lag is likely
because the MD samples were collected continuously over
a period of one hour, while blood was drawn at the end of
this one-hour period. However, even with these time
delays no significant correlation could be found.
In summary, subcutaneous MD does not reflect blood
Phe and Tyr concentrations in adults with PKU.
Conclusion
As Phe concentrations show only very slight fluctuations
over the day, a single blood sample seems to reflect meta-
bolic control in adult PKU patients in a reliable manner.
Most patients have their maximum diurnal Phe and mini-
mum Tyr concentrations in the morning. Microdialysis is
not advantageous for monitoring Phe and Tyr levels in
adult patients with PKU.
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